Kyra Schloenbach Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 920 S Main St, New Lexington, OH 43764 Phone: 740-404-7932 |
Chelsi Clark Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 920 S Main St, New Lexington, OH 43764 Phone: 740-342-5161 |
Mrs. Brooke Finck, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2550 Panther Dr Ne, New Lexington, OH 43764 Phone: 740-342-2556 |
News Archive
University of North Carolina Lineberger Comprehensive Cancer Center scientists have uncovered a potential therapeutic target for kidney cancers that have a common genetic change.
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that top-line data from part one of a two-part Phase 1 study of SPI-1620 in combination with docetaxel was presented in an oral presentation at the 12th International Conference on Endothelin, held in Cambridge, United Kingdom, from September 11-14, 2011. Part one of the study has been completed, while part two is ongoing.
Nathan Bryan, Ph.D., one of the world's leading experts on the critically important role of Nitric Oxide (NO) in the health of many of the body's organs and systems, said," understanding the vital effects of bacteria in the mouth is essential for health care providers, although it is not widely understood by the public."
A multidisciplinary team at Loyola Medicine is launching a clinical research study to determine the most prevalent factors impacting young women's pelvic health.
› Verified 7 days ago